Geographic expansion New product strategy Critical collaborations Market development

Corporate

Infection Preventi

on

Advancing the interests of industry, government and non-profit organizations in addressing preventable infection, worldwide.

Best practice governance Shared value partnerships Creative resource development

Public policy frameworks Infection control capacity

building programs Public-private partnerships International exchange

Government Non-Profit Organizations

Infection Prevention Partners

Expert insight for business, product & market development

Translating geographic needs into business opportunity

Prioritizing global opportunities

Shaping markets toward adoption

Facilitating commercial, government and nonprofit partnerships

Connecting with thought leaders worldwide

Policy solutions and partnerships

Public policy models and frameworks

Infection control capacity building programs

Public-private partnerships

Collaborations with public health, professional societies and industry

Governance and growth strategy

Guidance for start-ups

Best practice governance models

Shared value partnerships

Creative resource development

Business case development

Corporate GovernmentNon-Profit

Organizations

Infection Prevention Partners

Kathy Warye Chief Executive Officer

Named one of the “100 Most Powerful People in Healthcare” by Modern Healthcare Magazine for her influence in driving awareness of healthcare-associated infections (HAIs) and leadership in mobilizing a diverse community of stakeholders toward elimination of preventable HAIs.

Tangible Results Led infection prevention strategy development for BD, a $9B multinational

medical device & diagnostics company. Paved the way for market entry into skin antisepsis, a $1B opportunity space, via acquisition of CareFusion, a $6B infection prevention market leader.

Led transformation of the Association for Professionals in Infection Control & Epidemiology from an under-the-radar professional society to globally recognized leader in patient safety. Tripled revenue in 6 years.

Forged numerous industry partnerships to develop markets toward adoption of advanced infection control products such as MRSA reduction (BD GeneOhm); more effective skin antisepsis (CareFusion ChloraPrep); vascular access (Bard & BD) and advanced wound care (Covidien AMD).

Co-directed a 3-year market shaping initiative in China, a public-private partnership between government, industry and the China Hospital Association to develop a model hospital infection control program for the country.

Advanced ground breaking public policy solutions in the US to drive awareness and prevention of HAIs.

Infection Prevention Partners

Email: kwarye@infectionpreventionpartners.com

Phone: 202-460-5304

Website: www.infectionpreventionpartners.com

China Centers of Excellence partners, Peking Union Medical Hospital, Sept. 2014. CHA, MOH & BD, public-private partnership to build a model infection control program for the nation.

Commitment ceremony, China Centers of Excellence , Beijing 2012

Infection Prevention Partners